These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30622289)

  • 1. A renaissance of teleophthalmology through artificial intelligence.
    Korot E; Wood E; Weiner A; Sim DA; Trese M
    Eye (Lond); 2019 Jun; 33(6):861-863. PubMed ID: 30622289
    [No Abstract]   [Full Text] [Related]  

  • 2. The Current State of Teleophthalmology in the United States.
    Rathi S; Tsui E; Mehta N; Zahid S; Schuman JS
    Ophthalmology; 2017 Dec; 124(12):1729-1734. PubMed ID: 28647202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telemedicine and diabetic retinopathy.
    DeTore J; Rizzolo D
    JAAPA; 2018 Sep; 31(9):1-5. PubMed ID: 30153210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling Up Teleophthalmology for Diabetic Eye Screening: Opportunities for Widespread Implementation in the USA.
    Liu Y; Torres Diaz A; Benkert R
    Curr Diab Rep; 2019 Aug; 19(9):74. PubMed ID: 31375932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of Diabetic Retinopathy Using Artificial Intelligence and Tele-Ophthalmology.
    Kuklinski EJ; Henry RK; Shah M; Zarbin MA; Szirth B; Bhagat N
    J Diabetes Sci Technol; 2023 Nov; 17(6):1724-1725. PubMed ID: 37642475
    [No Abstract]   [Full Text] [Related]  

  • 6. Artificial intelligence for diabetic retinopathy screening, prediction and management.
    Gunasekeran DV; Ting DSW; Tan GSW; Wong TY
    Curr Opin Ophthalmol; 2020 Sep; 31(5):357-365. PubMed ID: 32740069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy.
    Galiero R; Pafundi PC; Nevola R; Rinaldi L; Acierno C; Caturano A; Salvatore T; Adinolfi LE; Costagliola C; Sasso FC
    J Diabetes Res; 2020; 2020():9036847. PubMed ID: 33123599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urban diabetic retinopathy teleophthalmology screening: results and impact at the service corridor.
    Boucher MC; El Yamani MEM
    Can J Ophthalmol; 2019 Jun; 54(3):359-366. PubMed ID: 31109477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of diabetic retinopathy as identified by teleophthalmology in rural Alberta.
    Nathoo N; Ng M; Rudnisky CJ; Tennant MT
    Can J Ophthalmol; 2010 Feb; 45(1):28-32. PubMed ID: 20130706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tele-ophthalmology for diabetic retinopathy in Canada-meeting the needs of a growing epidemic.
    Kanjee R; Dookeran RI
    Can J Ophthalmol; 2017 Nov; 52 Suppl 1():S13-S14. PubMed ID: 29074006
    [No Abstract]   [Full Text] [Related]  

  • 11. Teleophthalmology for the elderly population: A review of the literature.
    Fatehi F; Jahedi F; Tay-Kearney ML; Kanagasingam Y
    Int J Med Inform; 2020 Apr; 136():104089. PubMed ID: 32044698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telemedicine in diabetic retinopathy: current status and future directions.
    Das T; Raman R; Ramasamy K; Rani PK
    Middle East Afr J Ophthalmol; 2015; 22(2):174-8. PubMed ID: 25949074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New telemedicine solution targets diabetic retinopathy.
    Gabriel BA
    Caring; 2004 Jun; 23(6):48. PubMed ID: 15270330
    [No Abstract]   [Full Text] [Related]  

  • 14. The Muranga Teleophthalmology Study: A Comparison of Virtual (Teleretina) Assessment with in-person Clinical Examination to Diagnose Diabetic Retinopathy and Age-related Macular Degeneration in Kenya.
    Nanji K; Kherani IN; Damji KF; Nyenze M; Kiage D; Tennant MT
    Middle East Afr J Ophthalmol; 2020; 27(2):91-99. PubMed ID: 32874041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in examining cost-effectiveness of AI in diabetic retinopathy screening.
    Dismuke C
    Lancet Digit Health; 2020 May; 2(5):e212-e213. PubMed ID: 33328051
    [No Abstract]   [Full Text] [Related]  

  • 16. The era of artificial intelligence-based individualized telemedicine is coming.
    Jheng YC; Kao CL; Yarmishyn AA; Chou YB; Hsu CC; Lin TC; Hu HK; Ho TK; Chen PY; Kao ZK; Chen SJ; Hwang DK
    J Chin Med Assoc; 2020 Nov; 83(11):981-983. PubMed ID: 32568967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application.
    Bellemo V; Lim G; Rim TH; Tan GSW; Cheung CY; Sadda S; He MG; Tufail A; Lee ML; Hsu W; Ting DSW
    Curr Diab Rep; 2019 Jul; 19(9):72. PubMed ID: 31367962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison population.
    Aoki N; Dunn K; Fukui T; Beck JR; Schull WJ; Li HK
    Diabetes Care; 2004 May; 27(5):1095-101. PubMed ID: 15111527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient perceived value of teleophthalmology in an urban, low income US population with diabetes.
    Ramchandran RS; Yilmaz S; Greaux E; Dozier A
    PLoS One; 2020; 15(1):e0225300. PubMed ID: 31917793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Components of Telemedicine Programs for Diabetic Retinopathy.
    Horton MB; Silva PS; Cavallerano JD; Aiello LP
    Curr Diab Rep; 2016 Dec; 16(12):129. PubMed ID: 27796779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.